Page last updated: 2024-08-24

imiquimod and valacyclovir

imiquimod has been researched along with valacyclovir in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (37.50)29.6817
2010's2 (25.00)24.3611
2020's3 (37.50)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Snoeck, R1
Germain, M; Skelton, H; Smith, KJ; Yeager, J1
Brummitt, CF1
Bechtel, MA; Trout, W1
Sharma, DP; Singh, J; Sinha, S; Tandon, S1
Fung, MA; Opene, C; Silverstein, M1
Bouscarat, F; Boutolleau, D; Bucau, M; Burrel, S; Fidouh, N; Ghosn, J; Hachon, L; Joly, V; Khellaf, L; Lariven, S; Le Pluart, D; Thy, M1

Reviews

2 review(s) available for imiquimod and valacyclovir

ArticleYear
[Perspectives for the treatment and prevention of herpes simplex infections].
    Annales de dermatologie et de venereologie, 2002, Volume: 129, Issue:4 Pt 2

    Topics: 2-Aminopurine; Acyclovir; Aminoquinolines; Antiviral Agents; Cidofovir; Cytosine; Drug Therapy, Combination; Famciclovir; Herpes Simplex; Herpes Simplex Virus Vaccines; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Imiquimod; Interferon Inducers; Organophosphonates; Organophosphorus Compounds; Valacyclovir; Valine

2002
Sexually transmitted diseases.
    Clinical obstetrics and gynecology, 2015, Volume: 58, Issue:1

    Topics: Acyclovir; Aminoquinolines; Anti-Bacterial Agents; Antineoplastic Agents; Antiviral Agents; Chancre; Condylomata Acuminata; Female; Herpes Genitalis; Humans; Imiquimod; Papillomavirus Infections; Papillomavirus Vaccines; Penicillins; Podophyllotoxin; Sexually Transmitted Diseases; Syphilis, Cutaneous; Uterine Cervical Neoplasms; Valacyclovir; Valine

2015

Other Studies

6 other study(ies) available for imiquimod and valacyclovir

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Topical 5% imiquimod for the therapy of actinic cheilitis.
    Journal of the American Academy of Dermatology, 2002, Volume: 47, Issue:4

    Topics: Acyclovir; Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antiviral Agents; Cheilitis; Female; Humans; Imiquimod; Male; Middle Aged; Retrospective Studies; Stomatitis, Herpetic; Valacyclovir; Valine

2002
Imiquimod 5% cream for the treatment of recurrent, acyclovir-resistant genital herpes.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Feb-15, Volume: 42, Issue:4

    Topics: Acyclovir; Administration, Topical; Aged; Aminoquinolines; Antiviral Agents; Arthritis, Rheumatoid; Drug Resistance, Viral; Emollients; Female; Foscarnet; Herpes Genitalis; Humans; Imiquimod; Infusions, Intravenous; Treatment Outcome; Trifluridine; Valacyclovir; Valine

2006
Recalcitrant hypertrophic herpes genitalis in HIV-infected patient successfully treated with topical imiquimod.
    Dermatologic therapy, 2017, Volume: 30, Issue:3

    Topics: Acyclovir; Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Antiviral Agents; Drug Therapy, Combination; Herpes Genitalis; HIV Infections; Humans; Hypertrophy; Imiquimod; Immunocompromised Host; Male; Middle Aged; Valacyclovir; Valine

2017
Orf progressiva: giant progressive and destructive infections in the immunocompromised.
    Dermatology online journal, 2021, Jan-15, Volume: 27, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Antiviral Agents; Ciprofloxacin; Debridement; Drug Therapy, Combination; Ecthyma, Contagious; Humans; Imiquimod; Immunocompromised Host; Kidney Transplantation; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Superinfection; Valacyclovir

2021
Novel mutations in antiviral multiresistant HSV-2 genital lesion: A case report.
    Journal of medical virology, 2022, Volume: 94, Issue:12

    Topics: Acyclovir; Antiviral Agents; Cidofovir; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Genitalia; Herpes Simplex; Herpesvirus 2, Human; Humans; Imiquimod; Mutation; Obesity; Thymidine Kinase; Valacyclovir

2022